On Thursday, 2808 stocks advanced, 1539 declined, and 157 remained unchanged on the Bombay Stock Exchange with an advance-decline ratio of 1.82, indicating a positive closing. The trend of the major indices on Thursday’s trading is given in the table below.
On NSE, 109 securities advanced and closed at a new 52-week high, whereas 3 securities sank to close at their new 52-week lows. Nifty India Defence, Nifty Metal and Nifty IT were the biggest gainer. Nifty Auto and Nifty PSU Bank were the biggest loser.
HDFC Life Insurance (-1.40%) announced a ₹1,000 crore preferential issue of equity shares to promoter HDFC Bank Ltd. The insurer will issue 1.45 crore shares at ₹688.52 each, fully in equity (no convertibles), compliant with SEBI’s preferential allotment norms. Post issuance, HDFC Bank’s stake will rise marginally from 50.21% to 50.54%, consolidating promoter control, subject to shareholder and regulatory approvals.
Ashoka Buildcon (+1.60%) completed the timely redemption of its Series II NCDs worth ₹100 crore on 16 April 2026. The redemption covered 10,000 rated, listed, senior, unsecured, redeemable NCDs of ₹1,00,000 each, listed on the Wholesale Debt Segment of BSE.
Bharat Petroleum Corporation Limited (-0.81%), via its subsidiary Bharat PetroResources Ltd (BPRL), has announced the Final Investment Decision (FID) approval for the SEAP 1 oil & gas project in Brazil’s BM SEAL 11 block, granted by operator Petrobras on 13 April 2026.
BPCL holds an effective 26.40% stake, while Petrobras leads with 60%. The project will deploy FPSO P 81, designed to produce 120,000 barrels of oil/day and process 10 million cubic metres of gas/day, with contract signing expected shortly pending approvals.
Intellect Design Arena (+1.31%) announced a strategic partnership with Kuwait’s OnCost to deploy its eMACH.ai Retail 6DX platform across branches. The move shifts OnCost from legacy systems to a cloud native, microservices architecture, enabling omnichannel integration, precision inventory, faster checkout, and hyper personalised loyalty programs.
Firstsource Solutions (+10.83%) launched Kairos, an operating system designed to embed “Intelligence That Operates” into enterprise workflows. The platform addresses a 540 bps gap in operational performance between AI enabled firms and laggards, integrating intelligence from ambition to accountable outcomes. Early deployments show strong results: 66% productivity gain and 80% automation in healthcare denials triage, plus 25% cost savings and 83% faster onboarding in financial services KYC/AML, underscoring Kairos’ ability to convert AI into measurable efficiency.
Aditya Infotech (+1.52%), parent of CP Plus, has executed a 50:50 joint venture agreement with Orient Cables (India) Ltd to expand into the cables manufacturing segment. The JV will produce LAN cables, CCTV cables, terminated assemblies, connectors and allied products, supplying both partners’ networks. With equal shareholding, balanced board representation, and mutual decision making, the structure ensures joint control and integrated supply chain synergy across surveillance and cable solutions.
DCM Shriram (+0.89%) approved the transfer of 50% equity in Shriram Polytech Ltd (SPL) to Teknor Apex B.V. for $5.6 million cash consideration. Post transaction, SPL will be reclassified as a joint venture, with governance defined by a shareholders’ and share purchase agreement between DCM Shriram, SPL, and Teknor Apex. The partnership combines SPL’s domestic vinyl compound expertise with Teknor Apex’s global formulation strengths, aiming to deliver high performance, sustainable specialty polymer solutions and expand DCM Shriram’s advanced materials footprint.
Emcure Pharmaceuticals (-0.47%) announced a sharp price cut for Poviztra® (semaglutide injection), reducing the starting dose price by 55% to ₹3,999/month (0.25 mg) from ₹8,790. Across all strengths (0.25 mg to 2.4 mg), prices have been lowered by an average of 47%, effective 3 April 2026.
Zydus Lifesciences (+0.33%) received the Establishment Inspection Report (EIR) from the USFDA for its oncology injectable facility at SEZ 1, Ahmedabad, confirming successful closure of the inspection conducted in November 2025. The clearance validates its new isolator based injectable manufacturing line, a critical step for entry into the high value oncology generics market.
The top gainers and top losers of the major indices are given in the table below:
The closing values of the major Asian indices are given in the table below:
Moneylife Stockgraders
Moneylife Digital Team
16 April 2026
Guidelines
1. The Grader captures the three factors that determine investments: valuation, returns and price strength. Our grader captures these three parameters.
2. In this system, A is a...
Aarti Industries Enters Utilisation Phase after Years of Heavy Investment
Moneylife Digital Team
16 April 2026
Aarti Industries Limited (AIL), with a 40-year operating history, is a key player in India’s specialty chemicals sector, built on an integrated benzene and toluene value chain producing over 100 products across pharmaceuticals,...
Sanghvi Movers Ltd: Crane Demand Surges, but Expansion and Competition Weigh on Profitability
Moneylife Digital Team
15 April 2026
Sanghvi Movers Limited is emerging as a direct proxy on India’s infrastructure push and the Middle East’s capital expenditure (capex) boom, as demand for heavy-lift equipment surges across sectors from railways to petrochemicals. The...
Entero Healthcare: Building Scale in a Fragmented Market
Moneylife Digital Team
14 April 2026
The Indian pharmaceuticals industry was valued at US$50bn (billion) in FY23-24, comprising US$23.5bn in domestic consumption and US$26.5bn in exports. Ranking third globally by volume and 14th by value, the sector employs...